Barclays Maintains Labcorp Holdings at Equal-Weight, Raises Price Target to $380 from $330
Barclays has maintained its Equal-Weight rating on Labcorp Holdings while increasing its price target to $380 from $330.
Stocks · News reference
Analysts Update Price Targets for Labcorp Holdings Inc.
Following the company's third-quarter earnings report, financial institutions including Truist Securities and Baird have updated their price targets for Labcorp Holdings Inc.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- fiscal.ai
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Deutsche Bank Adjusts Labcorp Price Target to $355 From $306, Maintains Hold Rating
Deutsche Bank has increased its price target for Labcorp to $355 from $306 while maintaining a Hold rating.
Morgan Stanley Adjusts Price Target on Labcorp Holdings to $388 From $338
Morgan Stanley has revised its price target for Labcorp Holdings, increasing it to $388 from the previous $338.
UBS Adjusts Price Target on Labcorp to $420 From $380, Maintains Buy Rating
UBS has raised its price target for Labcorp to $420 from $380 while maintaining a Buy rating.